Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease

J Neurol. 2024 Jan;271(1):575-579. doi: 10.1007/s00415-023-11983-w. Epub 2023 Sep 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Erdheim-Chester Disease* / diagnostic imaging
  • Erdheim-Chester Disease* / drug therapy
  • Histiocytosis, Sinus* / diagnosis
  • Humans
  • Liquid Biopsy
  • Mutation / genetics
  • Proto-Oncogene Proteins B-raf / genetics

Substances

  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf